Screener
Stryker SYK Orthopaedics — Research, development and engineering expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Stryker’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 11:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000310764-26-000031
| Segment Results | Three Months / 2026 | Three Months / 2025 |
|---|---|---|
| Orthopaedics | 823 | 775 |
| Cost of sales | $2,114 | $1,950 |
| MedSurg and Neurotechnology | $231 | $208 |
| Orthopaedics | 146 | 158 |
| Segment research, development and engineering expenses | $377 | $366 |
| MedSurg and Neurotechnology | $930 | $859 |
| Orthopaedics | 880 | 925 |
| Segment selling, general and administrative expenses | $1,810 | $1,784 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Stryker's orthopaedics — research, development and engineering expenses?
- Stryker (SYK) reported orthopaedics — research, development and engineering expenses of $146M in Q1 2026.
- How has Stryker's orthopaedics — research, development and engineering expenses changed year-over-year?
- Stryker's orthopaedics — research, development and engineering expenses decreased by 7.6% year-over-year, from $158M to $146M.
- What is the long-term trend for Stryker's orthopaedics — research, development and engineering expenses?
- Over 3 years (2022 to 2025), Stryker's orthopaedics — research, development and engineering expenses has grown at a 4.4% compound annual growth rate (CAGR), from $477M to $542M.
- What does orthopaedics — research, development and engineering expenses mean?
- These are the costs incurred by the Orthopaedics segment to research, design, and develop new medical devices, implants, and surgical technologies. This investment is critical for maintaining market leadership in reconstructive orthopedics and driving future product innovation. High levels of spending indicate a commitment to long-term growth through a robust product pipeline.
Ask your AI about Stryker's orthopaedics — research, development and engineering expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude